Methyl 4-(aminomethyl)tetrahydro-2H-pyran-4-carboxylate hydrochloride, 97%, 250mg

Manganese (II) bromide tetrahydrate, 98.0%, 25g

3,5-Dihydro-1H-furo[3,4-c]pyrrole-4-carboxylic acid, 98%, 5g

N-Cyclohexylaniline, 95.0%, 25g

2,2'-Bibenzothiazoline>85.0%(T)5g

2-Amino-4,4,4-trifluoro-butyric acid ethyl ester hydrochloride, 95%, 100mg

3-chloro-5-methylimidazo[1,2-a]pyridine, 5g

5-(3-Bromo-4-fluorophenyl)pentanoic acid, 95%, 250mg

1,4-Benzenedicarboxylic acid, 2,5-bis[3-(ethylthio)propoxy]-, 1,4-dihydrazide, 500mg

4-Methyl-D-phenylalanine, >99%, 10g

ETHYL 3,3-DIMETHYL-4-NITROBUTANOATE, 97.0%, 250mg

TERT-BUTYL N-[(1R,3S)-3-HYDROXYCYCLOHEXYL]CARBAMATE, 95.0%, 10g

Plan fase S100x/1,25 inmersión en aceite objetivo corregido al infinito